Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 7.39% is in line with its 5-year average of 7.56%, around the middle of its 5-year range (3.31%–13.03%).
As of the fiscal period ended Wednesday, December 31, 2025. 17.30% above its 12-month average of 6.30%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
7.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
6.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
5.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
7.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
7.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
8.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
8.96%
CURRENT VS TTM AVG
+17.30%
CURRENT VS 3Y AVG
+31.09%
CURRENT VS 5Y AVG
-2.23%
CURRENT VS 10Y AVG
+3.49%
CURRENT VS 15Y AVG
-8.13%
CURRENT VS 20Y AVG
-17.53%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-13.36%
vs the sector median at left
Labcorp Holdings Inc.
Market Cap
$25.77B
Return on Invested Capital (ROIC)
7.39%
TTM Avg
6.30%
3Y Avg
5.64%
5Y Avg
7.56%
Market Cap
$25.96B
Return on Invested Capital (ROIC)
20.58%
TTM Avg
10.42%
3Y Avg
9.36%
5Y Avg
7.13%
Market Cap
$26.04B
Return on Invested Capital (ROIC)
8.43%
TTM Avg
7.70%
3Y Avg
8.24%
5Y Avg
10.04%
Market Cap
$25.02B
Return on Invested Capital (ROIC)
17.57%
TTM Avg
18.00%
3Y Avg
20.73%
5Y Avg
22.79%
Market Cap
$23.72B
Return on Invested Capital (ROIC)
13.62%
TTM Avg
14.65%
3Y Avg
16.90%
5Y Avg
17.70%
Market Cap
$28.06B
Return on Invested Capital (ROIC)
35.46%
TTM Avg
38.26%
3Y Avg
37.51%
5Y Avg
36.01%
Market Cap
$23.38B
Return on Invested Capital (ROIC)
-3.14%
TTM Avg
-4.79%
3Y Avg
9.55%
5Y Avg
20.42%
Market Cap
$28.88B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
13.40%
3Y Avg
11.07%
5Y Avg
9.62%
Market Cap
$22.45B
Return on Invested Capital (ROIC)
8.47%
TTM Avg
7.82%
3Y Avg
7.13%
5Y Avg
6.49%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $25.77B | 7.39% | 6.30% | 5.64% | 7.56% |
| Incyte Corporation (INCY)vs › | $25.96B | 20.58% | 10.42% | 9.36% | 7.13% |
| Quest Diagnostics Incorporated (DGX)vs › | $26.04B | 8.43% | 7.70% | 8.24% | 10.04% |
| Waters Corporation (WAT)vs › | $25.02B | 17.57% | 18.00% | 20.73% | 22.79% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.72B | 13.62% | 14.65% | 16.90% | 17.70% |
| Mettler-Toledo International Inc. (MTD)vs › | $28.06B | 35.46% | 38.26% | 37.51% | 36.01% |
| BioNTech SE (BNTX)vs › | $23.38B | -3.14% | -4.79% | 9.55% | 20.42% |
| DexCom, Inc. (DXCM)vs › | $28.88B | 16.61% | 13.40% | 11.07% | 9.62% |
| STERIS plc (STE)vs › | $22.45B | 8.47% | 7.82% | 7.13% | 6.49% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.16B | 8.84% | 8.56% | 8.37% | 9.38% |
ROIC
7.4%
ROE
10.8%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 7.39% |
| 2024-12-31 | 5.21% |
| 2023-12-31 | 3.31% |
| 2022-12-31 | 6.64% |
| 2021-12-31 | 13.03% |
| 2020-12-31 | 9.77% |
| 2019-12-31 | 6.21% |
| 2018-12-31 | 6.45% |
| 2017-12-31 | 9.22% |
| 2016-12-31 | 6.71% |
| 2015-12-31 | 4.61% |
| 2014-12-31 | 8.46% |
| 2013-12-31 | 9.85% |
| 2012-12-31 | 10.12% |
| 2011-12-31 | 10.47% |
| 2010-12-31 | 11.26% |
| 2009-12-31 | 13.87% |
| 2008-12-31 | 11.95% |
| 2007-12-31 | 11.57% |
| 2006-12-31 | 11.52% |
| 2005-12-31 | 10.55% |
| 2004-12-31 | 10.70% |
| 2003-12-31 | 9.97% |
| 2002-12-31 | 10.74% |
| 2001-12-31 | 11.69% |
| 2000-12-31 | 9.08% |
| 1999-12-31 | 6.45% |
| 1998-12-31 | 7.37% |
| 1997-12-31 | -4.17% |
| 1996-12-31 | -4.64% |
